# ETHACRYNATE SODIUM
> **ANDA208663** · Abbreviated New Drug Application (Generic) · Sponsor: STERIMAX · Approved 2020-06-09
## Drug
- **FDA Application Number:** ANDA208663
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ETHACRYNATE SODIUM
- **Generic name:** ETHACRYNATE SODIUM
- **Active ingredients:** ETHACRYNATE SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** STERIMAX
- **Manufacturer:** Leading Pharma, LLC
- **First approval:** 2020-06-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208663)
---
*AI Analytics · CC0 1.0*